Eli Lilly quits medical technology with Hybritech sale
This article was originally published in Clinica
Executive Summary
Eli Lilly has agreed to sell its San Diego-based diagnostics subsidiary Hybritech to Beckman Instruments. The sale brings an end to Lilly's interests in the diagnostics and medical devices field. The deal is expected to close on January 2nd, almost two years after Lilly originally announced it wanted to exit the medtech industry.